Search research articles
Contact Us
Filters
Showing results (61-70 of 186) with videos related to
Page
of 19
Sort By:
Behaviour Research and Therapy
|
September 27, 2000
Does the social concerns component of the anxiety sensitivity index belong to the domain of anxiety sensitivity or the domain of negative evaluation sensitivity?
L A McWilliams, S H Stewart, P S MacPherson
Steroids
|
December 1, 1981
Generally applicable 125 iodine-based radioimmunoassays for plasma progesterone
J E Corrie, W A Ratcliffe, J S Macpherson
Acta Chirurgica Scandinavica
|
January 1, 1981
Cancer of the head of the pancreas and choledochoduodenal junction: a clinical study of 88 Whipple resections
S Björck, J O Svensson, S Macpherson, et al.
Clinical Chemistry
|
April 1, 1981
A strategy for radioimmunoassay of plasma progesterone with use of a homologous-site 125I-labeled radioligand
J E Corrie, W M Hunter, J S Macpherson
BMJ (Clinical Research Ed.)
|
July 20, 2016
Embracing inherent uncertainty in advanced illness
B Kimbell, S A Murray, S Macpherson, et al.
Communications Chemistry
|
August 8, 2024
Selection of antibody-binding covalent aptamers
Noah Soxpollard, Sebastian Strauss, Ralf Jungmann, et al.
Human Reproduction (Oxford, England)
|
July 2, 2003
Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate
Jane S Fisher, S Macpherson, N Marchetti, et al.
Annals of the Royal College of Surgeons of England
|
May 23, 2023
Metastases from gastric cancer presenting as colorectal lesions: a report of two cases and systematic review
V L Fretwell, E G Kane, S MacPherson, et al.
Anti-Cancer Drug Design
|
October 1, 1995
Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs
I Meikle, J Cummings, J S Macpherson, et al.
Journal of Chromatography. B, Biomedical Applications
|
October 11, 1996
Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography
J Cummings, I Meikle, J S Macpherson, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 186) with videos related to
Sort By:
Page
of 19
Behaviour Research and Therapy
|
September 27, 2000
Does the social concerns component of the anxiety sensitivity index belong to the domain of anxiety sensitivity or the domain of negative evaluation sensitivity?
L A McWilliams, S H Stewart, P S MacPherson
Steroids
|
December 1, 1981
Generally applicable 125 iodine-based radioimmunoassays for plasma progesterone
J E Corrie, W A Ratcliffe, J S Macpherson
Acta Chirurgica Scandinavica
|
January 1, 1981
Cancer of the head of the pancreas and choledochoduodenal junction: a clinical study of 88 Whipple resections
S Björck, J O Svensson, S Macpherson, et al.
Clinical Chemistry
|
April 1, 1981
A strategy for radioimmunoassay of plasma progesterone with use of a homologous-site 125I-labeled radioligand
J E Corrie, W M Hunter, J S Macpherson
BMJ (Clinical Research Ed.)
|
July 20, 2016
Embracing inherent uncertainty in advanced illness
B Kimbell, S A Murray, S Macpherson, et al.
Communications Chemistry
|
August 8, 2024
Selection of antibody-binding covalent aptamers
Noah Soxpollard, Sebastian Strauss, Ralf Jungmann, et al.
Human Reproduction (Oxford, England)
|
July 2, 2003
Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate
Jane S Fisher, S Macpherson, N Marchetti, et al.
Annals of the Royal College of Surgeons of England
|
May 23, 2023
Metastases from gastric cancer presenting as colorectal lesions: a report of two cases and systematic review
V L Fretwell, E G Kane, S MacPherson, et al.
Anti-Cancer Drug Design
|
October 1, 1995
Identification of anthracenyl-dipeptide conjugates as novel topoisomerase I and II inhibitors and their evaluation as potential anticancer drugs
I Meikle, J Cummings, J S Macpherson, et al.
Journal of Chromatography. B, Biomedical Applications
|
October 11, 1996
Determination of the novel topoisomerase I inhibitor NU/ICRF 505 and its major metabolite in plasma, tissue and tumour by high-performance liquid chromatography
J Cummings, I Meikle, J S Macpherson, et al.
Page
of 19